Name: Elemental magnesium
Brand: Elemental magnesium
Availability: InStock
Rating: 3.0 (1 reviews)

Search instead for active

Ctiv FDA Approved Drugs

ABILIFY [Aripiprazole^{C₂₃H₂₇Cl₂N₃O₂}]

10mg (oral tablet)

15mg (oral tablet)

20mg (oral tablet)

2mg (oral tablet)

30mg (oral tablet)

Otsuka^{Nov 15, 2002}

Acute treatment of manic and mixed episodes associated with bipolar i disorder.
Adjunctive treatment of major depressive disorder (mdd).
Treatment of irritability associated with autistic disorder.
Treatment of major depressive disorder (mdd).
Treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar i disorder, adjunctive treatment of major depressive disorder, and treatment of irritability associated with autistic disorder.
Treatment of schizophrenia.

ACCUNEB [Albuterol Sulfate^{2C₁₃H₂₁NO₃H₂O₄S}]

eq 0.021% base (inhalation solution)

eq 0.042% base (inhalation solution)

Mylan Speciality Lp^{Apr 30, 2001}

Indicated for the relief of bronchospasm in patients 2-12 years of age with asthma (reversible obstructive airway disease).

ACTIVELLA [Estradiol^{C₁₈H₂₄O₂} : Norethindrone Acetate^{C₂₂H₂₈O₃}]

0.5mg : 0.1mg (oral tablet)

1mg : 0.5mg (oral tablet)

Amneal Pharms Llc^{Dec 28, 2006}

ACTOS [Pioglitazone Hydrochloride^{C₁₉H₂₀N₂O₃SClH}]

eq 15mg base (oral tablet)

eq 30mg base (oral tablet)

eq 45mg base (oral tablet)

Takeda Pharms Usa^{Jul 15, 1999}

Method of reducing side effects of active components admin to a diabetic by admin a chemical compound having formula (incl pioglitazone) in combination with an insulin secretion enhancer.

ADDYI [Flibanserin^{C₂₀H₂₁F₃N₄O}]

100mg (oral tablet)

Sprout Pharms^{Aug 18, 2015}

Use of flibanserin or a pharmaceutically acceptable acid addition salt thereof to treat hypoactive sexual desire disorder (hsdd).

AMABELZ [Estradiol^{C₁₈H₂₄O₂} : Norethindrone Acetate^{C₂₂H₂₈O₃}]

0.5mg : 0.1mg (oral tablet)

1mg : 0.5mg (oral tablet)

Lupin Ltd^{Jun 20, 2016}

AMYVID [Florbetapir F-18^{C₂₀H₂₅FN₂O₃}]

10-30ml (13.5-51mci/ml) (intravenous solution)

10-50ml (13.5-51mci/ml) (intravenous solution)

Avid Radiopharms Inc^{Apr 6, 2012}

Amyvid is a radioactive diagnostic agent for positron emission tomography (pet) imaging of the brain to estimate beta-amyloid neuritic plaque density in adult patients with cognitive impairment.

ANORO ELLIPTA [Umeclidinium Bromide^{C₂₉H₃₄NO₂Br} : Vilanterol Trifenatate^{C₂₄H₃₃Cl₂NO₅C₂₀H₁₆O₂}]

eq 0.0625mg base/inh : eq 0.025mg base/inh (inhalation powder)

Glaxosmithkline^{Dec 18, 2013}

Indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema..

APTIOM [Eslicarbazepine Acetate^{C₁₇H₁₆N₂O₃}]

200mg (oral tablet)

400mg (oral tablet)

600mg (oral tablet)

800mg (oral tablet)

Sunovion Pharms Inc^{Nov 8, 2013}

Approved indications: aptiom (eslicarbazepine acetate) is indicated as adjunctive treatment of partial-onset seizures and approved in patients with epilepsy. patent claims: in a method of treating a subject afflicted with epilepsy.
Method of treating epilepsy.
Monotherapy or adjunctive therapy for treatment of partial-onset seizures and approved in patients with epilepsy.

ARCAPTA NEOHALER [Indacaterol Maleate^{C₂₄H₂₈N₂O₃C₄H₄O₄}]

eq 75mcg base (inhalation powder)

Sunovion Pharms Inc^{Jul 1, 2011}

The long term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema.

AXIRON [Testosterone^{C₁₉H₂₈O₂}]

30mg/1.5ml actuation (transdermal solution, metered)

Eli Lilly And Co^{Nov 23, 2010}

A method of increasing the testosterone blood level of a person in need thereof.
A method of increasing the testosterone blood level of an adult male subject in need thereof.
A method of transdermal administration of a physiologically active agent to a subject..
A method of transdermally delivering testosterone.
Testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.

BEVESPI AEROSPHERE [Formoterol Fumarate^{2C₁₉H₂₄N₂O₄C₄H₄O₄2H₂O} : Glycopyrrolate^{C₁₉H₂₈NO₃Br}]

0.0048mg/inh : 0.0090mg/inh (inhalation aerosol, metered)

Astrazeneca Pharms^{Apr 25, 2016}

Use in the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd).

BRIVIACT [Brivaracetam^{C₁₁H₂₀N₂O₂}]

100mg (oral tablet)

10mg (oral tablet)

10mg/ml (oral solution)

25mg (oral tablet)

50mg (oral tablet)

50mg/5ml (10mg/ml) (intravenous solution)

75mg (oral tablet)

Ucb Inc^{May 12, 2016}

Treatment of partial-onset seizures as adjunctive therapy in patients with epilepsy aged 16 years and older with epilepsy.

BROVANA [Arformoterol Tartrate^{C₁₉H₂₄N₂O₄C₄H₆O₆}]

eq 0.015mg base/2ml (inhalation solution)

Sunovion^{Oct 6, 2006}

For the long term treatment, twice daily (morning and evening) maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema.

CALDOLOR [Ibuprofen^{C₁₃H₁₈O₂}]

800mg/8ml (100mg/ml) (intravenous solution)

Cumberland Pharms^{Jun 11, 2009}

Management of mild to moderate pain, management of moderate to severe pain as an adjunct to opioid analgesics in a critically ill patient with intravenous ibuprofen in need thereof.
Management of mild to moderate pain, management of moderate to severe pain as an adjunct to opioid analgesics, reduction in fever through anti-inflammatory, analgesic, and antipyretic activity.
Management of mild to moderate pain, management of moderate to severe pain as an adnunct to opioid analgesics, reduction in fever through anti inflammatory, analgesic, and antipyretic activity.
Methods of treating pain, inflammation and/or fever in a critically ill patient with intravenous ibuprofen in need thereof.
Methods of treating pain, inflammation and/or fever with intravenous ibuprofen such that mean arterial blood pressure does not increase the dosage interval.

COMBIGAN [Brimonidine Tartrate^{C₁₁H₁₀BrN₅C₄H₆O₆} : Timolol Maleate^{C₁₃H₂₄N₄O₃SC₄H₄O₄}]

0.2% : eq 0.5% base (ophthalmic solution/drops)

Allergan^{Oct 30, 2007}

Reduction of elevated intraocular pressure (iop) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled iop. dose is one drop of combigan in the affected eye twice daily.
Reduction of elevated intraocular pressure in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled iop.
Reduction of elevated intraocular pressure in patients with glaucoma or ocular hypertension.
Reduction of elevated intraocular pressure.
Reduction of intraocular pressure in patients with elevated intraocular pressure or glaucoma.

COMBIPATCH [Estradiol^{C₁₈H₂₄O₂} : Norethindrone Acetate^{C₂₂H₂₈O₃}]

0.05mg/24hr : 0.14mg/24hr (transdermal film, extended release)

0.05mg/24hr : 0.25mg/24hr (transdermal film, extended release)

Noven Pharms Inc^{Aug 7, 1998}

CUBICIN [Daptomycin^{C₇₂H₁₀₁N₁₇O₂₆}]

500mg/vial (intravenous powder)

Cubist Pharms Llc^{Sep 12, 2003}

Treatment of the following infections: complicated skin and skin structure infections and staphylococcus aureus bloodstream infections (bacteremia) including those with right-sided infective endocarditis.

CUBICIN RF [Daptomycin^{C₇₂H₁₀₁N₁₇O₂₆}]

500mg/vial (intravenous powder)

Cubist Pharms Llc^{Jul 6, 2016}

Treatment of the following infections: complicated skin and skin structure infections and staphylococcus aureus bloodstream infections (bacteremia) including those with right-sided infective endocarditis.

DAKLINZA [Daclatasvir Dihydrochloride^{C₄₀H₅₀N₈O₆2ClH}]

eq 30mg base (oral tablet)

eq 60mg base (oral tablet)

eq 90mg base (oral tablet)

Bristol-myers Squibb^{Jul 24, 2015}

Method of inhibiting hepatitis c virus with daklinza and at least one additional compound having anti-hcv activity.
Method of inhibiting hepatitis c virus.

DAYTRANA [Methylphenidate^{C₁₄H₁₉NO₂}]

10mg/9hr (1.1mg/hr) (transdermal film, extended release)

15mg/9hr (1.6mg/hr) (transdermal film, extended release)

20mg/9hr (2.2mg/hr) (transdermal film, extended release)

30mg/9hr (3.3mg/hr) (transdermal film, extended release)

Noven Pharms Inc^{Apr 6, 2006}

For the treatment of attention deficit hyperactivity disorder (adhd).
Method for transdermally delivering a drug to a user in need thereof.

DDAVP [Desmopressin Acetate^{C₄₆H₆₄N₁₄O₁₂S₂C₂H₄O₂3H₂O}]

0.004mg/ml (injection injectable)

0.01% (nasal solution)

0.1mg (oral tablet)

0.2mg (oral tablet)

Ferring Pharms Inc^{Mar 30, 1984}

DDAVP (NEEDS NO REFRIGERATION) [Desmopressin Acetate^{C₄₆H₆₄N₁₄O₁₂S₂C₂H₄O₂3H₂O}]

0.01mg/spray (nasal spray, metered)

Ferring Pharms Inc^{Aug 7, 1996}

DESMOPRESSIN ACETATE [Desmopressin Acetate^{C₄₆H₆₄N₁₄O₁₂S₂C₂H₄O₂3H₂O}]

0.004mg/ml (injection injectable)

0.01% (nasal solution)

0.01mg/spray (nasal spray, metered)

0.1mg (oral tablet)

0.2mg (oral tablet)

Hospira^{Aug 28, 2000}
Sun Pharm Inds Ltd^{Jan 25, 2013}
Teva Pharms Usa^{Oct 15, 1997}
Bausch And Lomb^{Jan 25, 1999}
Actavis Labs Fl Inc^{Jul 1, 2005}
Apotex Inc^{Mar 7, 2006}
Glenmark Pharms Ltd^{May 28, 2015}
Heritage Pharma^{May 26, 2017}
Impax Labs Inc^{Jan 25, 2006}
Mylan Pharms Inc^{Jun 27, 2014}

DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) [Desmopressin Acetate^{C₄₆H₆₄N₁₄O₁₂S₂C₂H₄O₂3H₂O}]

0.01mg/spray (nasal spray, metered)

Apotex Inc^{Jan 27, 2005}
Sun Pharma Global^{Dec 23, 2013}

DETROL LA [Tolterodine Tartrate^{C₂₂H₃₁NOC₄H₆O₆}]

2mg (oral capsule, extended release)

4mg (oral capsule, extended release)

Pharmacia And Upjohn^{Dec 22, 2000}

Treatment of overactive bladder. treatment of urinary incontinence..

ENDOMETRIN [Progesterone^{C₂₁H₃₀O₂}]

100mg (vaginal insert)

Ferring^{Jun 21, 2007}

Endometrin is a progesterone indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an assisted reproductive technology (art) treatment program for infertile women.
Support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an assisted reproductive technology (art) treatment program for infertile women.

ESTRADIOL AND NORETHINDRONE ACETATE [Estradiol^{C₁₈H₂₄O₂} : Norethindrone Acetate^{C₂₂H₂₈O₃}]

0.5mg : 0.1mg (oral tablet)

1mg : 0.5mg (oral tablet)

Breckenridge Pharm^{Jun 9, 2011}
Mylan Labs Ltd^{Feb 10, 2017}
Teva Pharms Usa^{Mar 8, 2012}
Barr^{May 11, 2010}

FACTIVE [Gemifloxacin Mesylate^{C₁₈H₂₀FN₅O₄CH₄O₃S}]

eq 320mg base (oral tablet)

Lg Chem Ltd^{Apr 4, 2003}

Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria.
Use of quinolone compounds against anaerobic pathogenic bacteria.
Use of quinolone compounds against atypical upper respiratory pathogenic bacteria.
Use of quinolone compounds against pneumococcal pathogenic bacteria.
Use of quinolone compounds against quinolone-resistant pneumococcal pathogenic bacteria.

FIBRICOR [Fenofibric Acid^{C₁₇H₁₅ClO₄}]

105mg (oral tablet)

35mg (oral tablet)

Aralez Pharms Inc^{Aug 14, 2009}

Adjunctive therapy to diet in patients with elevated cholesterol and/or lipid levels.
Adjunctive therapy to diet in patients with hyperlipidemias.
Adjunctive therapy to diet in patients with mixed dyslipidemia.
Adjunctive therapy to diet to patients with hypertriglyceridemia.

GELNIQUE [Oxybutynin Chloride^{C₂₂H₃₁NO₃ClH}]

10%(100mg/packet) (transdermal gel)

Allergan Sales Llc^{Jan 27, 2009}

Treatment of overactive bladder by application of oxybutynin chloride gel to skin.
Treatment of patients with an overactive bladder with symptoms of urinary frequency, urgency, or urge incontinence.

GEMIFLOXACIN MESYLATE [Gemifloxacin Mesylate^{C₁₈H₂₀FN₅O₄CH₄O₃S}]

eq 320mg base (oral tablet)

Orchid Hlthcare^{Jun 15, 2015}

GIAZO [Balsalazide Disodium^{C₁₇H₁₃N₃O₆2Na2H₂O}]

1.1gm (oral tablet)

Valeant Pharms Intl^{Feb 3, 2012}

Treatment of mildly to moderately active ulcerative colitis in male patients.

GONITRO [Nitroglycerin^{C₃H₅N₃O₉}]

0.4mg/packet (sublingual powder)

Pohl Boskamp^{Jun 8, 2016}

INCRUSE ELLIPTA [Umeclidinium Bromide^{C₂₉H₃₄NO₂Br}]

eq 62.5mcg base/inh (inhalation powder)

Glaxo Grp England^{Apr 30, 2014}

Indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema..

INTUNIV [Guanfacine Hydrochloride^{C₉H₉Cl₂N₃OClH}]

eq 1mg base (oral tablet, extended release)

eq 2mg base (oral tablet, extended release)

eq 3mg base (oral tablet, extended release)

eq 4mg base (oral tablet, extended release)

Shire^{Sep 2, 2009}

Treatment of attention-deficit hyperactivity disorder.

INVEGA SUSTENNA [Paliperidone Palmitate^{C₃₉H₅₇FN₄O₄}]

117mg/0.75ml (117mg/0.75ml) (intramuscular suspension, extended release)

156mg/ml (156mg/ml) (intramuscular suspension, extended release)

234mg/1.5ml (156mg/ml) (intramuscular suspension, extended release)

39mg/0.25ml (39mg/0.25ml) (intramuscular suspension, extended release)

78mg/0.5ml (78mg/0.5ml) (intramuscular suspension, extended release)

Janssen Pharms^{Jul 31, 2009}

Treatment of schizoaffective disorder as a monotherapy and as an adjunct to mood stabilizers or antidepressants.
Treatment of schizophrenia.

JUXTAPID [Lomitapide Mesylate^{C₃₉H₃₇F₆N₃O₂CH₄O₃S}]

eq 10mg base (oral capsule)

eq 20mg base (oral capsule)

eq 30mg base (oral capsule)

eq 40mg base (oral capsule)

eq 5mg base (oral capsule)

eq 60mg base (oral capsule)

Aegerion^{Dec 21, 2012}

A dosing regimen for the treatment of hypercholesterolemia and hyperlipidemia in patients with homozygous familial hypercholesterolemia using at least three step-wise increasing doses.
A dosing regimen for the treatment of hypercholesterolemia and hyperlipidemia in patients with homozygous familial hypercholesterolemia using at least three step-wise increasing doses.
Treatment of hypercholesterolemia by decreasing the amount or activity of microsomal triglyceride transfer protein in patients with homozygous familial hypercholesterolemia.
Treatment of hypercholesterolemia, hyperlipidemia and hyperlipoproteinemia in patients with homozygous familial hypercholesterolemia.

KAZANO [Alogliptin Benzoate^{C₁₈H₂₁N₅O₂C₇H₆O₂} : Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

eq 12.5mg base : 1gm (oral tablet)

eq 12.5mg base : 500mg (oral tablet)

Takeda Pharms Usa^{Jan 25, 2013}

Method of treating diabetes comprising administering a compound such as alogliptin.
Method of treating diabetes comprising administering alogliptin.
Methods of lowering elevated post prandial blood glucose levels comprising administering a dipeptidyl peptidase inhibitor.
Methods of modifying glucose metabolism and treating diabetes comprising administering a dipeptidyl peptidase inhibitor and one or more other therapeutic agents such as metformin.
Methods of reducing the side effects of active components administered to a diabetic patient comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
Methods of treating diabetes comprising administering a dipeptidyl peptidase inhibitor and metformin.

KYNAMRO [Mipomersen Sodium^{C₂₃₀H₃₀₅N₆₇O₁₂₂P₁₉S₁₉1₉Na}]

200mg/ml (200mg/ml) (subcutaneous solution)

Kastle Theraps Llc^{Jan 29, 2013}

Adjunctive therapy to lipid-lowering medications and diet to reduce low density lipoprotein-cholesterol, apolipoprotein b, total cholesterol, and non-high density lipoprotein cholesterol in pts with homozygous familial hypercholesterolemia.

LAMICTAL ODT [Lamotrigine^{C₉H₇Cl₂N₅}]

100mg (oral tablet, orally disintegrating)

200mg (oral tablet, orally disintegrating)

25mg (oral tablet, orally disintegrating)

50mg (oral tablet, orally disintegrating)

Glaxosmithkline Llc^{May 8, 2009}

Lamictal is an antiepileptic drug (aed) indicated for: epilepsy-adjunctive therapy in patients greater than or equal to 2 years of age: (1.1) partial seizures primary generalized tonic-clonic seizures.

LASTACAFT [Alcaftadine^{C₁₉H₂₁N₃O}]

0.25% (ophthalmic solution/drops)

Allergan^{Jul 28, 2010}

Method for preventing itching associated with allergic conjunctivitis.

MINIRIN [Desmopressin Acetate^{C₄₆H₆₄N₁₄O₁₂S₂C₂H₄O₂3H₂O}]

0.01mg/spray (nasal spray, metered)

Ferring^{Sep 16, 2002}

MINITRAN [Nitroglycerin^{C₃H₅N₃O₉}]

0.1mg/hr (transdermal film, extended release)

0.2mg/hr (transdermal film, extended release)

0.4mg/hr (transdermal film, extended release)

0.6mg/hr (transdermal film, extended release)

Valeant Pharms^{Aug 30, 1996}
Valeant Pharms North^{Aug 30, 1996}
Medicis^{Aug 30, 1996}

MYRBETRIQ [Mirabegron^{C₂₁H₂₄N₄O₂S}]

25mg (oral tablet, extended release)

50mg (oral tablet, extended release)

Apgdi^{Jun 28, 2012}

For the treatment of overactive bladder (oab) with symptoms of urge urinary incontinence, urgency, and urinary frequency.

NATESTO [Testosterone^{C₁₉H₂₈O₂}]

5.5mg/0.122gm actuation (nasal gel, metered)

Aytu Bioscience Inc^{May 28, 2014}

A method of testosterone replacement therapy comprising the step of nasally administering to a patient in need of such treatment an effective amount of testosterone gel formulation..
Nasal administration of a testosterone gel to a patient to treat the patient for a condition associated with a deficiency or absence of endogenous testosterone.

NEOPROFEN [Ibuprofen Lysine^{C₁₃H₁₈O₂C₆H₁₄N₂O₂}]

eq 20mg base/2ml (eq 10mg base/ml) (intravenous injectable)

Recordati Rare^{Apr 13, 2006}

Closure of a clnically significant patent ductus arteriosus in premature infants weighing between 500 and 1500g, who are no more than 32 weeks gestational age when usual medical management is ineffective.
Treatment of patent ductus arteriosus.

NESINA [Alogliptin Benzoate^{C₁₈H₂₁N₅O₂C₇H₆O₂}]

eq 12.5mg base (oral tablet)

eq 25mg base (oral tablet)

eq 6.25mg base (oral tablet)

Takeda Pharms Usa^{Jan 25, 2013}

Method of treating diabetes comprising administering a compound such as alogliptin.
Method of treating diabetes comprising administering alogliptin.
Methods of lowering elevated post prandial blood glucose levels comprising administering a dipeptidyl peptidase inhibitor.
Methods of modifying glucose metabolism and treating diabetes comprising administering a dipeptidyl peptidase inhibitor and one or more other therapeutic agents such as metformin.
Methods of reducing the side effects of active components administered to a diabetic patient comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
Methods of treating diabetes comprising administering a dipeptidyl peptidase inhibitor and metformin.

NEURACEQ [Florbetaben F-18^{C₂₁H₂₆FNO₃}]

30ml (1.4-135mci/ml) (intravenous solution)

Piramal Imaging^{Mar 19, 2014}

Neuraceq is a radioactive diagnostic agent for positron emission tomography (pet) imaging of the brain to estimate p-amyloid neuritic plaque density in adult patients with cognitive impairment.

NITRO-DUR [Nitroglycerin^{C₃H₅N₃O₉}]

0.1mg/hr (transdermal film, extended release)

0.2mg/hr (transdermal film, extended release)

0.3mg/hr (transdermal film, extended release)

0.4mg/hr (transdermal film, extended release)

0.6mg/hr (transdermal film, extended release)

0.8mg/hr (transdermal film, extended release)

Uspharma^{Apr 4, 1995}

NITROGLYCERIN [Nitroglycerin^{C₃H₅N₃O₉}]

0.1mg/hr (transdermal film, extended release)

0.2mg/hr (transdermal film, extended release)

0.3mg (sublingual tablet)

0.4mg (sublingual tablet)

0.4mg/hr (transdermal film, extended release)

0.4mg/spray (sublingual spray, metered)

0.6mg (sublingual tablet)

0.6mg/hr (transdermal film, extended release)

2% (transdermal ointment)

5mg/ml (injection injectable)

Mylan Technologies^{Feb 6, 1998}
Hercon Pharm^{Oct 30, 1998}
Dr Reddys Labs Inc^{Aug 26, 2016}
Perrigo Israel^{Sep 20, 2013}
Fougera Pharms Inc^{Jul 8, 1988}
Luitpold^{May 24, 1988}

NITROGLYCERIN IN DEXTROSE 5% [Nitroglycerin^{C₃H₅N₃O₉}]

10mg/100ml (injection injectable)

20mg/100ml (injection injectable)

40mg/100ml (injection injectable)

Baxter Hlthcare^{Dec 29, 1989}
Hospira^{Aug 31, 1990}

NITROLINGUAL PUMPSPRAY [Nitroglycerin^{C₃H₅N₃O₉}]

0.4mg/spray (sublingual spray, metered)

Pohl Boskamp^{Jan 10, 1997}

Angina pectoris.

NITROMIST [Nitroglycerin^{C₃H₅N₃O₉}]

0.4mg/spray (sublingual aerosol, metered)

Mist Pharms Llc^{Nov 2, 2006}

NITROSTAT [Nitroglycerin^{C₃H₅N₃O₉}]

0.3mg (sublingual tablet)

0.4mg (sublingual tablet)

0.6mg (sublingual tablet)

Pfizer Pharms^{May 1, 2000}

NOCTIVA [Desmopressin Acetate^{C₄₆H₆₄N₁₄O₁₂S₂C₂H₄O₂3H₂O}]

0.00083mg/spray (nasal spray, metered)

0.00166mg/spray (nasal spray, metered)

Serenity Pharms Llc^{Mar 3, 2017}

A method of treating nocturia due to nocturnal polyuria in adults.

OFIRMEV [Acetaminophen^{C₈H₉NO₂}]

1gm/100ml (10mg/ml) (iv (infusion) solution)

Mallinckrodt Ip^{Nov 2, 2010}

Management of mild to moderate pain, management of moderate to severe pain as an adjunct to opioid analgesics, reduction in fever through analgesic and antipyretic activity.
Management of moderate to severe pain as an adjunct to opioid analgesics.

ORBACTIV [Oritavancin Diphosphate^{C₈₆H₉₇Cl₃N₁₀O₂₆2H₃O₄P}]

eq 400mg base/vial (iv (infusion) powder)

The Medicines Co^{Aug 6, 2014}

Treatment of bacterial skin and skin structure infections using a single dose.
Treatment of bacterial skin and skin structure infections.

OSENI [Alogliptin Benzoate^{C₁₈H₂₁N₅O₂C₇H₆O₂} : Pioglitazone Hydrochloride^{C₁₉H₂₀N₂O₃SClH}]

eq 12.5mg base : eq 15mg base (oral tablet)

eq 12.5mg base : eq 30mg base (oral tablet)

eq 12.5mg base : eq 45mg base (oral tablet)

eq 25mg base : eq 15mg base (oral tablet)

eq 25mg base : eq 30mg base (oral tablet)

eq 25mg base : eq 45mg base (oral tablet)

Takeda Pharms Usa^{Jan 25, 2013}

Method of treating diabetes comprising administering a compound such as alogliptin.
Method of treating diabetes comprising administering alogliptin.
Methods of lowering elevated post prandial blood glucose levels comprising administering a dipeptidyl peptidase inhibitor.
Methods of modifying glucose metabolism and treating diabetes comprising administering a dipeptidyl peptidase inhibitor and one or more other therapeutic agents such as metformin.
Methods of reducing the side effects of active components administered to a diabetic patient comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
Methods of treating diabetes comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
Methods of treating diabetes comprising administering a dipeptidyl peptidase inhibitor and metformin.

OXTELLAR XR [Oxcarbazepine^{C₁₅H₁₂N₂O₂}]

150mg (oral tablet, extended release)

300mg (oral tablet, extended release)

600mg (oral tablet, extended release)

Supernus Pharms^{Oct 19, 2012}

Adjunctive therapy in the treatment of partial seizures.

OXYTROL [Oxybutynin^{C₂₂H₃₁NO₃}]

3.9mg/24hr (transdermal film, extended release)

Allergan Sales Llc^{Feb 26, 2003}

Treatment of patients with an overactive bladder with symptoms of urinary frequency, urgency, or urge incontinence.

OXYTROL FOR WOMEN [Oxybutynin^{C₂₂H₃₁NO₃}]

OTC

3.9mg/24hr (transdermal film, extended release)

Allergan Sales Llc^{Jan 25, 2013}

Treatment of patients with an overactive bladder.

PATADAY [Olopatadine Hydrochloride^{C₂₁H₂₃NO₃ClH}]

eq 0.2% base (ophthalmic solution/drops)

Novartis Pharms Corp^{Dec 22, 2004}

Method of treating allergic conjunctivitis.

PAZEO [Olopatadine Hydrochloride^{C₂₁H₂₃NO₃ClH}]

eq 0.7% base (ophthalmic solution/drops)

Novartis Pharms Corp^{Jan 30, 2015}

Treatment of ocular itching associated with allergic conjunctivitis.

PERFOROMIST [Formoterol Fumarate^{2C₁₉H₂₄N₂O₄C₄H₄O₄2H₂O}]

0.02mg/2ml (inhalation solution)

Mylan Speclt^{May 11, 2007}

Maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (copd).

PICATO [Ingenol Mebutate^{C₂₅H₃₄O₆}]

0.015% (topical gel)

0.05% (topical gel)

Leo Labs^{Jan 23, 2012}

To inhibit the proliferative activity of neoplastic cells.
To stimulate the immune system to induce t cell proliferation.
Treatment of actinic keratosis.
Use of ingenol mebutate to treat actinic keratosis.

QUILLICHEW ER [Methylphenidate Hydrochloride^{C₁₄H₁₉NO₂ClH}]

20mg (oral tablet, extended release, chewable)

30mg (oral tablet, extended release, chewable)

40mg (oral tablet, extended release, chewable)

Pfizer Inc^{Dec 4, 2015}

A method of providing a subject with therapeutically effective amount of racemic methylphenidate by orally administering to said subject a single methylphenidate extended release chewable tablet according to claim 1.

QUILLIVANT XR [Methylphenidate Hydrochloride^{C₁₄H₁₉NO₂ClH}]

5mg/ml (oral for suspension, extended release)

Nextwave Pharms^{Sep 27, 2012}

Method of treating attention deficit hyperactivity disorder by administering the composition of claim 1.
Treating a patient having a condition susceptible to treatment with methylphenidate, such as adhd, by administering the formulation recited in claims 1 or 2.
Treatment of a patient by administering the formulation recited in claim 1 or claim 23.

RECTIV [Nitroglycerin^{C₃H₅N₃O₉}]

0.4% (intra-anal ointment)

Forest Labs Inc^{Jun 21, 2011}

RESTASIS [Cyclosporine^{C₆₂H₁₁₁N₁₁O₁₂}]

0.05% (ophthalmic emulsion)

Allergan^{Dec 23, 2002}

Increase tear production in patients with keratoconjunctivitis sicca (dry eye)..
Increase tear production to treat patients with keratoconjunctivitis sicca (dry eye)..

RESTASIS MULTIDOSE [Cyclosporine^{C₆₂H₁₁₁N₁₁O₁₂}]

0.05% (ophthalmic emulsion)

Allergan^{Oct 27, 2016}

Increase tear production in patients with keratoconjunctivitis sicca (dry eye)..
Increase tear production to treat patients with keratoconjunctivitis sicca (dry eye)..

REXULTI [Brexpiprazole^{C₂₅H₂₇N₃O₂S}]

0.25mg (oral tablet)

0.5mg (oral tablet)

1mg (oral tablet)

2mg (oral tablet)

3mg (oral tablet)

4mg (oral tablet)

Otsuka Pharm Co Ltd^{Jul 10, 2015}

Adjunctive treatment of major depressive disorder (mdd).
Treatment of schizophrenia.

RITALIN LA [Methylphenidate Hydrochloride^{C₁₄H₁₉NO₂ClH}]

10mg (oral capsule, extended release)

20mg (oral capsule, extended release)

30mg (oral capsule, extended release)

40mg (oral capsule, extended release)

Novartis^{Apr 10, 2004}

Treatment of attention deficit hyperactivity disorder using methylphenidate bi-modal release profile extended-release capsules.

RYTARY [Carbidopa^{C₁₀H₁₄N₂O₄H₂O} : Levodopa^{C₉H₁₁NO₄}]

23.75mg : 95mg (oral capsule, extended release)

36.25mg : 145mg (oral capsule, extended release)

Impax Labs Inc^{Jan 7, 2015}

Method of providing a therapeutically effective and stable median blood plasma level of levodopa.
Treatment of parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
Treatment of parkinson's disease.
Treatment of parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
Treatment of post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
Treatment of post-encephalitic parkinsonism.

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.

WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for reference only. Many of these treatments may be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field. The owner of this website will not be held liable for any injuries and deaths cause by following any home remedies. We have no control of what is posted.

Home Remedies for Ctiv

PREVENT HEADACHE
Take 200 to 400 mg of active elemental magnesium before the onset of a headache. Check with your doctor first if you have kidney problems.ThomasFuh | November 5th, 2017

PREGNANCY [contraception]
Emergency contraception is to only be used after unprotected sex, not for regular birth control. Emergency contraception that contains the same hormone used in many birth control pills - just at a higher dose. Helps prevent pregnancy. It should not be used as regular birth control because it's not as effective.
Mechanism - hormoneShizs | July 15th, 2018

CORONAVIRUS [COVID-19]
Remdesivir is a novel antiviral drug in the class of nucleotide analogs. It was developed by Gilead Sciences as a treatment for Ebola virus disease and Marburg virus infections, though it has subsequently also been found to show antiviral activity against other single stranded RNA viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, Nipah virus, Hendra virus, and coronaviruses.Jose3124 | February 15th, 2020

DEPRESSION [major depressive disorder]
St. John's Wort can be used to relieve anxiety and act as an antidepressant. Take as directed. Approved for as a medicine in Germany. Not recognized in the United States as an effective antidepressant. The plant is poisonous to livestock. Contain a phytochemical chemicals, hyperforin and hypericin, which are make skin sensitive to light with extended use.
Mechanism - Hypericum perforatumJlaiii | May 1st, 2020

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Ctiv FDA Approved Drugs

Home Remedies for Ctiv